Nepopt 0.1%
Nepafenac 0.1%
FDA approved treatment of pain and inflammation after cataract surgery
(Current Medical Research & Opinion 2006)
Healthcare Professionals login
Nepopt 0.1%
Nepafenac 0.1%
GREATER STERILITY assurance due to filling inside a barrier isolator
(WHO Good Manufacturing Practices 2011 | Pharmaceutical Manufacturing 2003)
View Research Library
Nepopt 0.1%
Nepafenac 0.1%
FDA approved sources of API and medical grade plastic
Watch Video
Nepopt
Nepafenac 0.1%
Nepafenac Eye Drops in medical-grade PE bottles manufactured inside barrier-isolator.
Each mL of solution contains 1mg of nepafenac
Available in a pack of 5mL medical-grade PE bottle.
For topical use only.
Product Information
Indications
For the prevention and treatment of pain and inflammation associated with cataract surgery and reduction in risk of macular oedema associated with cataract surgery in diabetic patients
Contraindications
Hypersensitivity to the active substance or to any of the excipients or to other NSAIDs.
Adverse Effects
Capsular opacity
Decreased visual acuity
Foreign body sensationSticky sensation
Dosage
Instil 1 drop in the affected eye(s), three times daily, as per the following dosing schedule:
On the day prior to cataract surgery
On the day of surgery
For the first two weeks postoperatively
Additional Information/ Precautions
Shake well before use
The product should not be injected
Avoid sunlight during treatment with NEPOPT
For prescribing information,
Please Click Here
Previous
Next
Zoom In
Zoom Out
100%
Page:
/ 2
Member Log In
×
Mobile Number or Email Address
Receive Link
Not Registered? Please Sign Up
PMDC Number
Full Name
Email Address
Mobile Number
(e.g. 03xxxxxxxxx)
Hospital/Clinic Name & Address
Speciality
--Select--
GP
Consultant
Surgeon
Other
How Did You Hear About Us?
--Select--
Fellow doctor
Our representative
Other
Sign Up
